yumizen G800

HORIBA Medical’s D-dimer immunoassay displays excellent analytical performance in independent evaluation study

HORIBA Medical says that its novel haemostatic immunoassay, Yumizen G DDi 2, has been independently validated for the rapid quantification of D-dimer. Scientists from the Hematology Department, University Hospital of Clermont-Ferrand, have successfully evaluated its analytical performance [1]. Using HORIBA Medical’s Yumizen G800 fully automated haemostasis analyzer, they detected venous thromboembolism (VTE) with excellent accuracy, […]

Beckman Coulter Biomek NGeniuS

Beckman Coulter launches powerful Biomek NGeniuS automated liquid handling system

Beckman Coulter has launched their Biomek NGeniuS liquid handling system. The compact instrument automates the labour-intensive process of manual library construction and reagent transfers, helping free up researchers to focus on the science, not the workflow while also reducing the possibility of errors – all at the touch of a dial.

olympus apx100

New easy-to-use Olympus APX100 all-in-one microscope delivers top quality images

Built with renowned Olympus optics, intuitive software, a powerful AI and a suite of smart features, the APX100 system combines the ease of use of an all-in-one microscope with publication-quality images to make life science research more efficient. Designed for labs and imaging core facilities, the microscope’s small footprint, built-in anti-vibration mechanism and light-shielded optics […]

Atik ChemiMOS

Atik Cameras launches high-res ChemiMOS optimised for long exposures

Atik Cameras, a specialist designer and manufacturer of advanced scientific cameras, has launched ChemiMOS, the first in a series of high-resolution complementary metal oxide semiconductor (CMOS) cameras.

scopio haematology digital cell morphology platform

Beckman Coulter and Scopio Labs partner to accelerate adoption of haematology digital cell morphology platform

Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a MedTech company that develops AI-powered workflow solutions, have established a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms. Scopio’s technology employs full-field imaging and AI decision support to eliminate manual microscopy, while providing laboratory professionals and clinicians a […]

accerlerate diagnostics

Accelerate Diagnostics receives CE mark for Accelerate Arc system

Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, has received CE marking of its new Accelerate Arc Module and BC kit.

coriolis campus

Coriolis Pharma to build new campus in Martinsried-Munich

Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new campus as the next step in its growth strategy.

lifespin

Lifespin to collaborate wth Biobank Graz to expand database of metabolic profiles for novel oncology diagnostics platform

Regensburg, Germany-based Lifespin, has entered a collaborative agreement with Biobank Graz and the Clinical Division of Oncology of the Medical University of Graz to expand its database of metabolic human health profiles in the field of oncology. Under the agreement, Lifespin will be able to analyze and capture the metabolic profiles from more than 25,000 […]

Medix Biochemica

Medix Biochemica acquires Bioresource Technology

Medix Biochemica has acquired 100 percent of the shares of Bioresource Technology (BRT) to broaden its base matrix capabilities and further strengthen its local presence in the US market. As a result of this partnership, Medix Biochemica will provide its customers with a comprehensive offering of raw materials for their IVD quality control products. The […]

Minaris

Ixaka and Minaris Regenerative Medicine sign tech transfer, manufacturing agreement for cell therapy candidate REX-001

Ixaka, an integrated cell and gene therapy company, and Minaris Regenerative Medicine, a leading contract development and manufacturing service provider for the cell and gene therapy industry, have signed an agreement to enable technology transfer as well as clinical and commercial manufacture of REX-001, Ixaka’s lead autologous multi-cell therapy (MCT) being developed for the treatment […]